Pain is a personal, subjective experience that involves sensory, emotional and behavioural factors associated with actual or potential tissue injury. It is defi ned by the International Association for the Study of Pain as 'An unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage'. 1 Most of us at some stage in our lives have experienced pain. The most com mon type of pain that springs to mind is the acute or inflammatory pain associ ated with a bee sting or toothache. Most of us have felt the emotional, non-physi cal pain associated with watching a loved one experience physical or emotional trauma. Indeed, in the western world, one in three of us will also experience chronic pain most commonly associated with backache, headaches or persist ent post-surgical pain, costing the USA alone over $100 million in lost income and insurance costs. 2 So in essence there are many types of pain that can vary in their perceived intensity, character, duration, frequency, site, associated dis ability and emotional impact.
It is well known that the perception of pain will vary due to many factors, for example: gender, age, ethnicity and pain experience. Soldiers working in a war zone will have a much higher pain threshold than the rest of us. It is also acknowledged that stress and anxi ety will significantly reduce one's pain threshold. Pain itself causes anxiety and depression thus compounding the unpleasant experience. In essence pain is a combination of physical sensation with a significant emotional and cog nitive component, which is refl ected by the parts of the brain activated during pain stimulus as seen during functional MRI scanning (Fig. 1) .
Only the patient can experience their pain and unfortunately due to our lim ited vocabulary, description or expres sion of the pain experience is often severely compromised. Thus assessment of pain is often difficult and subjective. As dentists we are the unsung heroes of acute pain management and anxi ety in our patients. We consistently see patients whom, without masochistic tendencies, would rather be anywhere else aside from the dental chair under going injections and dental treatment. Our profession is unique in that we are trained as undergraduates in exposure prone techniques with competency in local analgesia and patient management in stressful conditions during dental treatment. Most medical students learn these skills as postgraduates.
So what has changed in our under standing of acute or chronic pain?
The onset of the 21st century has been an incredibly exciting time in pain biology.
Recent studies in basic pain research
Characteristics include resolution of have revealed numerous novel targets pain when irritant stimulus is removed for the advent of new pain therapies. Major advances range from molecular studies that have identifi ed transduction proteins in pain neurons, and genetic variation in pain modulation, to cortical imaging studies, which reveal how pain is experienced on a cognitive level. 2, 3 Pain is induced by tissue damage that results in cell death and subse quent release of intracellular factors (proteases) causing activation of the phospholipid pathway, the kinin path way, mast cells releasing histamine and platelet aggregation, resulting in serotonin release. These factors initiate depolarisation of local pain responsive nerve fibres (A delta fibres display pain and cold sensitivity and C fi bres display warm and pain sensitivity) via newly discovered pain receptors or ion chan nels. The evoked potential is relayed through primary to secondary neurons (in the dorsal horn of the spinal cord for most sensory neurons but within the trigeminal nucleus for the trigeminal sensory fibres), ultimately evoking terti ary neuron activation in the cortex. This not only results in the sensation of pain and a physical response (withdrawal from the noxious stimulus) but a down ward neural response that causes nerve induced inflammation at the injured site. Neuroinflammation causes the bulk of the inflammatory response at the injured site. Different types of neurons, recep tors, channels and transmitters have been identified in the peripheral versus central neural pathways, improving our understanding of the mechanisms of existing analgesics.
The two main types of pain

Healthy acute 'nociceptive pain' (sprains, bone fractures, burns, bumps, bruises, infl ammation [from an infection or arthritic disorder])
Nociceptors are the nerves which sense and respond to parts of the body which suffer from damage. The pain is typi cally well localised, constant, and often with an aching or throbbing quality. Vis ceral pain is the subtype of nociceptive pain that involves the internal organs. It tends to be episodic and poorly localised due to the slow conduction by C fi bres. and inflammation subsides, and that it tends to respond well to treatment with opioids and anti-infl ammatory drugs. Peripheral neuropathy is alarmingly prevalent in the UK and diabetes is the most common cause (diabetic burn ing foot). Other causes include chronic alcohol use, exposure to other toxins (including many chemotherapies), vita min deficiencies, HIV infection and a large variety of other medical condi tions. Chronic pain is defined as pain lasting longer than three months, or pain that is persistent after the cause of inflammation is no longer present. This chronic state involves complex neu roplastic mechanisms including pain memory, sensitisation and potentiation by either central, peripheral or a combi nation of both components of the nerv ous system. This process is essentially understood to be a disease of the nerv ous system and is characterised by lack of response to opioids or non-steroidal anti-inflammatory drugs (NSAIDs). The efficacy of gabapentin, the 5% lidocaine patch, tramadol hydrochloride and tri cyclic antidepressants (TCAs) has been consistently demonstrated in multi ple randomised controlled trials. 4 Thus acute and chronic pain are separate con ditions requiring differing strategies in assessment and management.
New techniques in the measure ment and assessment of pain
Functional magnetic resonance imag ing (fMRI) is a system whereby a con scious pain can be stimulated (noxious, olfactory, visual, auditory) and the changes in blood supply to areas of the brain can be identifi ed by differ entiation of oxygenated versus deoxy genated blood (Fig. 1) . This technology has revolutionised central pain path way activity in man and to some extent has replaced animal experiments.
Researchers have reported that in chronic pain conditions, the patient's reported visual analogue scale (VAS) correlates with the brain vascular activity, thus providing us with a potentially objective 'in vivo' pain measure in man.
Laboratory techniques have also assisted us in visualising pain 'down the microscope'. By using immunohistochem istry we can label specific pain receptors on nerve tissue in biopsies harvested after assessing the patient. Commonly in neuropathic pain there is degeneration of the peripheral nociceptors and rela tive increase in expression of pain chan nel receptors (diabetic pain, vulvadynia, irritable bowel syndrome, breast pain). 5 This technique has been applied to toothache (Fig. 2a) and the phenomenon or 'bed to bench' research is unravelus perceive chronic orofacial pain. The of increased pain channels has also been ling and will continue to unravel the neurovascular pain is predominantly V1 reported in burning mouth syndrome (Fig. 2b) . Calcium channel imaging also allows the researcher to evaluate in vivo cellular activity when challenged with a known receptor adjuvant.
Modality sensory testing is used to assess the activity of the pain-specifi c nerve fibres. A delta fi bres respond to cooling and pain and C fi bres respond to warming and pain. By using cooling and warming stimuli, hyperactivity can be identified and recorded objectively. This form of testing comprises part of a group of tests referred to as quantitative sen sory testing, which is gaining popularity in the assessment of neuropathic pain.
Genetics of pain. It is proposed that approximately 30,000 genes of the human genome might be involved in pain mediation. As previously stated in this article, several sodium channels have been identified as key players in neuropathic pain. There are some famil ial conditions whereby certain sodium ion channels are absent, rendering those affected unable to feel pain, resulting in considerable tissue damage. Genes asso ciated with sodium channel expression include SCN1A, discovered to be cause of familial hemiplegic migraine (FHM), and SCN9A in neuropathic pain as well as in inability to experience pain. Other genes have also been identified in modulat ing pain, including GTP cyclohydrolase (GCH1), which modulates sensitivity to pain in normal individuals and liability to chronic pain, and catechol-O-methyl transferase (COMT) and the cytochrome P450 variant allele CYP3A5, which modulate the genetic response to opioid medications in humans.
By combining clinical and laboratory methods of assessment, translational complex mechanisms leading to pain. There are already over 50 phase 1 tri als worldwide, assessing specifi c pain receptor blocking agents, a novel and potentially revolutionary method of pre venting pain. Thanks to recent develop ments, we clinicians are infi nitely better equipped to counsel our patients in our understanding of the mechanisms of their pain, which undoubtedly assists the patient in coming to terms with their pain. Overall, one can remain optimis tic that over the next decade signifi cant developments will minimise patient suf fering due to pain.
Trigeminal pain
The trigeminal (three twins) is a sensory nerve which takes up the bulk of the sensory cortex of the human mind. It is no wonder that when we experience pain from the three regions supplied by this sensory nerve, we can think of little else. Dentists are trained well in the causes of healthy acute infl ammatory pain, but less well in chronic pain. Medical stu dents have minimal exposure to supra clavicular pain attributable to dental or ENT conditions and their main exposure is to trigeminal neuralgia during their neurosurgical rotation. It is due to these phenomena that chronic trigeminal pain often falls within the 'pavement cracks' between different specialists, often resulting in conflicting advice to long suffering patients seeking relief from their suffering.
There are many attempts in classify ing orofacial pain. The main categories are topographical (odontogenic versus non-odontogenic) and chronic versus acute. A recent cluster analysis 6 (Fig.  3 ) has revolutionised the way many of or ophthalmic division pain, compris ing mainly of headaches and giant cell arteritis. The new phenomenon of medi cal overuse headache is not included in this analysis and is an increasing prob lem in the western world, requiring three months of 'cold turkey' therapy before effective treatment of the original head ache can be initiated.
The neuralgia group includes trigemi nal neuralgia (typical and atypical; always bare in mind patients under 40 years must have multiple sclerosis excluded), post-herpetic neuralgia (post shingles pain, which is 60% increased likelihood if the patient is over 50 years of age) and post-traumatic neuralgia (causalgia, commonly seen in post-oper ative cases [breast surgery 30% of cases, hernia surgery 30% of cases, spinal sur gery, and knee surgery 20% of cases]). The idiopathic group includes burning mouth syndrome, which increasingly is believed to be a small fi bre neuropa thy (much like burning foot in diabetic neuropathy), although as yet the cause is unknown.
Temporomandibular joint pain is a complex problem involving possible muscle or ligamentous strains, cartilage misplacement or damage, arthritides, pathology and psychometric elements. Pain in the joints is often present with out any clinical or radiographic evidence of mechanical dysfunction. In contra diction, mechanical and anatomical dysfunction is also commonly present with no associated pain. This heter ogenous group of patients provide the practitioner with plenty of diffi culties in management but most respond to sim ple reversible interventions, for example giving up chewing gum, or simple lower soft splints and reassurance.
The outlying conditions outwith this cluster analysis included persistent idi opathic orofacial pain (atypical facial pain, atypical odontalgia). Some believe that this group contains patients with causlagia, as many patients' chronic pain is initiated with dental surgical inter vention. They may present with persist ent post-traumatic pain due to peripheral sensory nerve branch damage caused by local anaesthesia or surgery. They are a quadrants of extracted teeth, having undergone hours of dental restorative treatment resulting in multiple extrac tions with no relief from the pain. There is increasing evidence for spe cific psychological and medical manage ment of many of these chronic orofacial pain conditions. It is imperative to spend time listening to the patient, taking an exhaustive history, thorough exami nation and an awareness of up-to-date often a multidisciplinary team. Often this investment of one-on-one assess ment will itself empower the patient to understand and cope with their pain. 
